-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Emtricitabine-[15N,d2]
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2714436-53-8.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2714436-53-8 |
| Description | Emtricitabine-[15N,d2] is a labelled Emtricitabine. It is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner. A nucleoside analog structurally related to Lamivudine. |
Product Information
| Synonyms | 4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone-d2,15N2; (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine-d2,15N2; (-)-2'-Deoxy-5-fluoro-3'-thiacytidine-d2,15N2; BW 1592-d2,15N2; BW 524W91-d2,15N2; Coviracil-d2,15N2; Emtriva-d2,15N2; (-)-FTC-d2,15N2 |
| Molecular Weight | 250.25 |
| Molecular Formula | C8H8D2FN2[15N]O3S |
| Purity | ≥98% |
| Solubility | Chloroform, Dichloromethane, DMSO |
| Appearance | Powder |
| Storage | Store at -20°C |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| PSA | 87.38000 |
| Target | HIV; Reverse Transcriptase; Endogenous Metabolite |
